These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 34090750)

  • 1. SARS-CoV-2 vaccine-induced cerebral venous thrombosis.
    Ciccone A
    Eur J Intern Med; 2021 Jul; 89():19-21. PubMed ID: 34090750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Geeraerts T; Guilbeau-Frugier C; Garcia C; Memier V; Raposo N; Bonneville F; Gales C; Darcourt J; Voisin S; Ribes A; Piel-Julian M; Bounes F; Albucher JF; Roux FE; Izopet J; Telmon N; Olivot JM; Sié P; Bauer J; Payrastre B; Liblau RS
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37236806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report.
    Di Pietro M; Dono F; Consoli S; Evangelista G; Pozzilli V; Calisi D; Barbone F; Bonanni L; Onofrj M; De Angelis MV; Sensi SL
    Neurol Sci; 2022 May; 43(5):2951-2956. PubMed ID: 35217969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
    Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.
    Alhashim A; Hadhiah K; Al Khalifah Z; Alhaddad FM; Al ARhain SA; Bin Saif FH; Abid A; Al Gamdi O; Alsulaiman F; AlQarni M
    Am J Case Rep; 2022 Feb; 23():e934744. PubMed ID: 35136010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine.
    Saleh A; Collins J
    Aust J Gen Pract; 2021 Nov; 50():. PubMed ID: 34781321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia].
    Hvas AM; Ostrowski SR; Frederiksen H; Kampmann P; Stensballe J
    Ugeskr Laeger; 2021 Jul; 183(29):. PubMed ID: 34356021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia.
    Pang E; Ghosh S; Chemmanam T; Grove C; Phillips T
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35042731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase.
    van de Munckhof A; Lindgren E; Kleinig TJ; Field TS; Cordonnier C; Krzywicka K; Poli S; Sánchez van Kammen M; Borhani-Haghighi A; Lemmens R; Scutelnic A; Ciccone A; Gattringer T; Wittstock M; Dizonno V; Devroye A; Elkady A; Günther A; Cervera A; Mengel A; Chew BLA; Buck B; Zanferrari C; Garcia-Esperon C; Jacobi C; Soriano C; Michalski D; Zamani Z; Blacquiere D; Johansson E; Cuadrado-Godia E; Vuillier F; Bode FJ; Caparros F; Maier F; Tsivgoulis G; Katzberg HD; Duan J; Burrow J; Pelz J; Mbroh J; Oen J; Schouten J; Zimmermann J; Ng K; Garambois K; Petruzzellis M; Carvalho Dias M; Ghiasian M; Romoli M; Miranda M; Wronski M; Skjelland M; Almasi-Dooghaee M; Cuisenier P; Murphy S; Timsit S; Coutts SB; Schönenberger S; Nagel S; Hiltunen S; Chatterton S; Cox T; Bartsch T; Shaygannejad V; Mirzaasgari Z; Middeldorp S; Levi MM; Kremer Hovinga JA; Jood K; Tatlisumak T; Putaala J; Heldner MR; Arnold M; Aguiar de Sousa D; Ferro JM; Coutinho JM;
    Stroke; 2022 Oct; 53(10):3206-3210. PubMed ID: 36082668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral Venous Sinus Thrombosis and Papilledema in Vaccine-Induced Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination.
    Donaldson L; Qian J; Lutchman C; AlShafai L; Margolin E
    J Neuroophthalmol; 2023 Mar; 43(1):e16-e18. PubMed ID: 36729051
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.
    Liu Y; Shao Z; Wang H
    Thromb Res; 2022 Jan; 209():75-79. PubMed ID: 34894531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2022 Feb; 48(1):8-14. PubMed ID: 34695859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia.
    Yahyavi-Firouz-Abadi N; Naik RP
    Neuroradiol J; 2022 Apr; 35(2):247-249. PubMed ID: 34333995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-induced immune thrombotic thrombocytopenia.
    Klok FA; Pai M; Huisman MV; Makris M
    Lancet Haematol; 2022 Jan; 9(1):e73-e80. PubMed ID: 34774202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review.
    Aguiar de Sousa D; Romoli M; Sánchez Van Kammen M; Heldner MR; Zini A; Coutinho JM; Arnold M; Ferro JM
    Stroke; 2022 Jun; 53(6):1892-1903. PubMed ID: 35240862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience.
    Geeraerts T; Montastruc F; Bonneville F; Mémier V; Raposo N;
    Anaesth Crit Care Pain Med; 2021 Aug; 40(4):100889. PubMed ID: 34033927
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources.
    Greinacher A; Langer F; Makris M; Pai M; Pavord S; Tran H; Warkentin TE
    J Thromb Haemost; 2022 Jan; 20(1):149-156. PubMed ID: 34693641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccine-induced immune thrombotic thrombocytopenia; extremely rare adverse event with major potential consequences].
    Middeldorp S
    Ned Tijdschr Geneeskd; 2021 May; 165():. PubMed ID: 34346643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Iba T; Levy JH; Warkentin TE
    Crit Care Med; 2022 Jan; 50(1):e80-e86. PubMed ID: 34259661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.